CAS RN: 1237745-91-3
4,8-Dichloro-7-methoxy-2-[4-(trifluoromethyl)-1,3-thiazol-2-yl]quinoline
Product Availability
Choose a grade to view its available package options.
1 package records0 with current stock1 grade group
| Batch No. | Package | Availability | Lead Time | Inquiry |
| Batchno.20260324 |
100mg |
Out of stock |
15 business days | Inquiry |
GET A QUOTE
1237745-91-3 / 2-(4,8-dichloro-7-methoxyquinolin-2-yl)-4-(trifluoromethyl)-1,3-thiazole
Standard CAS: 1237745-91-3
Multi CAS: No
Basic Information
CAS
1237745-91-3
Multi CAS
No
Molecular Formula
C14H7Cl2F3N2OS
Molecular Weight
379.200000
Exact Mass
377.960824
SMILES
COC1=C(C2=C(C=C1)C(=CC(=N2)C3=NC(=CS3)C(F)(F)F)Cl)Cl
InChI
InChI=1S/C14H7Cl2F3N2OS/c1-22-9-3-2-6-7(15)4-8(20-12(6)11(9)16)13-21-10(5-23-13)14(17,18)19/h2-5H,1H3
InChIKey
HJTXJWVDZYBCBT-UHFFFAOYSA-N
Computed Properties
Structural Parameters
Heavy atom count
23
Aromatic heavy atom count
15
Fraction Csp3
0.14
Rotatable bonds
2
H-bond acceptors
4
Molar refractivity
84.42
TPSA
35.01
LogP / Solubility
WLOGP
5.69
MLOGP
5.03
XLogP3
5.1
Consensus LogP
5.27
Log S (ESOL)
-6.13
Class (ESOL)
Insoluble
Log S (Ali)
-6.78
Class (Ali)
Insoluble
Log S (SILICOS-IT)
-7.09
Class (SILICOS-IT)
Insoluble
ADME
GI absorption
Low
BBB permeant
No
P-gp substrate
No
CYP1A2 inhibitor
Yes
CYP2C19 inhibitor
Yes
CYP2C9 inhibitor
Yes
CYP2D6 inhibitor
No
CYP3A4 inhibitor
Yes
Log Kp (skin permeation)
-0.99
Drug-likeness / Medicinal Chemistry
Lipinski
Yes
Ghose
No
Veber
Yes
Egan
Yes
Muegge
No
Bioavailability score
0.55
Leadlikeness
No
Synthetic Accessibility
2.5